The top medtech stories of early 2017

Share

Donald Trump medtech

[Image courtesy of White House]

The new Trump administration and Republican Congress – and all the accompanying change and uncertainty –is the major story for the medical device industry.

But there are many other medtech stories worth noting from the first quarter of 2017. There was an FDA warning over Abbott’s Absorb bioresorbable stent, a continued spate of M&A deals, a slew of cardiology research breakthroughs including a customizable robotic heart out of Harvard, and much more.

Here are the top medical device stories of early 2017.

Next>>

(And check out Medical Design & Outsourcing’s April 11 webinar about the top medtech stories of early 2017.) 

DeviceTalks West: Expertise you need to know

textadimage Medical device suppliers are light years away from the days when they merely filled orders to spec for medtech OEMs – as a visit to the upcoming DeviceTalks West will quickly confirm.

From incorporating steerability into catheters to getting validation and testing done right, the companies serving the medical device industry have become specialized experts in their own right.

Read on to discover five example of medical device expertise to be had at DeviceTalks West, which runs Dec. 11–12 in Orange County, Calif.

Pages: 1 2 3 4 5 6

Speak Your Mind

*